Results 121 to 130 of about 3,241 (225)

Mathematical model of hormone sensitive prostate cancer treatment using leuprolide: A small step towards personalization. [PDF]

PLoS One, 2022
Foryś U, Nahshony A, Elishmereni M.
europepmc   +1 more source

[Male contraception-scientific foundations and contemporary progress]. [PDF]

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
Zitzmann M.
europepmc   +1 more source

PFAS endocrine disruption affecting pubertal development: exposure-response is steeper below median PFAS serum concentrations. [PDF]

Environ Health
van Larebeke N, Voorspoels S, Den Hond E, Leermakers M, Schoeters G.   +4 more
europepmc   +1 more source

Medizin. [PDF]

CME (Berl), 2022
Facharztmagazine R.
europepmc   +1 more source

[Malarial antigens in the era of mRNA vaccines]. [PDF]

Monatsschr Kinderheilkd, 2022
Borkens Y.
europepmc   +1 more source

Immunohistochemical study of Rho-kinase pathway expression in a mouse model of prostate hypertrophy for preliminary study of progressive prostate cancer model establishment. [PDF]

Transl Androl Urol
Yang YM, Kitagawa K, Hirata Y, Moriwaki M, Ono T, Chiang YT, Chen KC, Shigemura K.   +7 more
europepmc   +1 more source

[Metastatic castration-resistant prostate cancer-what are rational sequential treatment options?] [PDF]

Urologie, 2023
Horak J, Petrausch U, Omlin A.
europepmc   +1 more source

Sex-related hormonal variances and clinical outcomes in TAVR patients. [PDF]

Clin Res Cardiol
Mousa Basha M, Al-Kassou B, Weber M, Beiert T, Bakhtiary F, Zimmer S, Nickenig G, Goody PR, Shamekhi J.   +8 more
europepmc   +1 more source

Hashimoto's Thyroiditis and Female Infertility: A Clinical and Statistical Investigation of Endocrine and Ovarian Markers. [PDF]

J Clin Med
Popa EC, Maghiar L, Maghiar TA, Brihan I, Georgescu LM, Toderaș BA, Sachelarie L, Hurjui LL, Huniadi A.   +8 more
europepmc   +1 more source